Medical Care

Global Regenerative Medicine Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for Regenerative Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Regenerative Medicine.
The Regenerative Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Regenerative Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, by Material Sources and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Regenerative Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
J & J (DePuy Synthes)
Medtronic
Zimmer Biomet
Stryker
Allergan
MiMedx Group
Organogenesis
Fujifilm Cellular Dynamics
Osiris Therapeutics
Vcanbio
CCBC
Cytori
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast
AMAG Pharmaceuticals (CBR)
ViaCord
CordLife
Integra LifeSciences
Nuvasive
Evergen
Japan Tissue Engineering
Segment by Type
Cell Therapy
Tissue Engineering
Biomaterial
Other
Segment by Material Sources
Autologous
Allogeneic
Xenogeneic
Synthetic
Segment by End User
Children
Young Adults
Elderly
Segment by Application
Dermatology
Cardiovascular
CNS
Orthopedic
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Material Sources etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Regenerative Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Regenerative Medicine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cell Therapy
1.2.3 Tissue Engineering
1.2.4 Biomaterial
1.2.5 Other
1.3 Market by Material Sources
1.3.1 Global Regenerative Medicine Market Size Growth Rate by Material Sources: 2020 VS 2024 VS 2031
1.3.2 Autologous
1.3.3 Allogeneic
1.3.4 Xenogeneic
1.3.5 Synthetic
1.4 Market by End User
1.4.1 Global Regenerative Medicine Market Size Growth Rate by End User: 2020 VS 2024 VS 2031
1.4.2 Children
1.4.3 Young Adults
1.4.4 Elderly
1.5 Market by Application
1.5.1 Global Regenerative Medicine Market Growth by Application: 2020 VS 2024 VS 2031
1.5.2 Dermatology
1.5.3 Cardiovascular
1.5.4 CNS
1.5.5 Orthopedic
1.5.6 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Regenerative Medicine Market Perspective (2020-2031)
2.2 Global Regenerative Medicine Growth Trends by Region
2.2.1 Global Regenerative Medicine Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Regenerative Medicine Historic Market Size by Region (2020-2025)
2.2.3 Regenerative Medicine Forecasted Market Size by Region (2026-2031)
2.3 Regenerative Medicine Market Dynamics
2.3.1 Regenerative Medicine Industry Trends
2.3.2 Regenerative Medicine Market Drivers
2.3.3 Regenerative Medicine Market Challenges
2.3.4 Regenerative Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Regenerative Medicine Players by Revenue
3.1.1 Global Top Regenerative Medicine Players by Revenue (2020-2025)
3.1.2 Global Regenerative Medicine Revenue Market Share by Players (2020-2025)
3.2 Global Top Regenerative Medicine Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Regenerative Medicine Revenue
3.4 Global Regenerative Medicine Market Concentration Ratio
3.4.1 Global Regenerative Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Regenerative Medicine Revenue in 2024
3.5 Global Key Players of Regenerative Medicine Head office and Area Served
3.6 Global Key Players of Regenerative Medicine, Product and Application
3.7 Global Key Players of Regenerative Medicine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Regenerative Medicine Breakdown Data by Type
4.1 Global Regenerative Medicine Historic Market Size by Type (2020-2025)
4.2 Global Regenerative Medicine Forecasted Market Size by Type (2026-2031)
5 Regenerative Medicine Breakdown Data by Application
5.1 Global Regenerative Medicine Historic Market Size by Application (2020-2025)
5.2 Global Regenerative Medicine Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Regenerative Medicine Market Size (2020-2031)
6.2 North America Regenerative Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Regenerative Medicine Market Size by Country (2020-2025)
6.4 North America Regenerative Medicine Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Regenerative Medicine Market Size (2020-2031)
7.2 Europe Regenerative Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Regenerative Medicine Market Size by Country (2020-2025)
7.4 Europe Regenerative Medicine Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Regenerative Medicine Market Size (2020-2031)
8.2 Asia-Pacific Regenerative Medicine Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Regenerative Medicine Market Size by Region (2020-2025)
8.4 Asia-Pacific Regenerative Medicine Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Regenerative Medicine Market Size (2020-2031)
9.2 Latin America Regenerative Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Regenerative Medicine Market Size by Country (2020-2025)
9.4 Latin America Regenerative Medicine Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Regenerative Medicine Market Size (2020-2031)
10.2 Middle East & Africa Regenerative Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Regenerative Medicine Market Size by Country (2020-2025)
10.4 Middle East & Africa Regenerative Medicine Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 J & J (DePuy Synthes)
11.1.1 J & J (DePuy Synthes) Company Details
11.1.2 J & J (DePuy Synthes) Business Overview
11.1.3 J & J (DePuy Synthes) Regenerative Medicine Introduction
11.1.4 J & J (DePuy Synthes) Revenue in Regenerative Medicine Business (2020-2025)
11.1.5 J & J (DePuy Synthes) Recent Development
11.2 Medtronic
11.2.1 Medtronic Company Details
11.2.2 Medtronic Business Overview
11.2.3 Medtronic Regenerative Medicine Introduction
11.2.4 Medtronic Revenue in Regenerative Medicine Business (2020-2025)
11.2.5 Medtronic Recent Development
11.3 Zimmer Biomet
11.3.1 Zimmer Biomet Company Details
11.3.2 Zimmer Biomet Business Overview
11.3.3 Zimmer Biomet Regenerative Medicine Introduction
11.3.4 Zimmer Biomet Revenue in Regenerative Medicine Business (2020-2025)
11.3.5 Zimmer Biomet Recent Development
11.4 Stryker
11.4.1 Stryker Company Details
11.4.2 Stryker Business Overview
11.4.3 Stryker Regenerative Medicine Introduction
11.4.4 Stryker Revenue in Regenerative Medicine Business (2020-2025)
11.4.5 Stryker Recent Development
11.5 Allergan
11.5.1 Allergan Company Details
11.5.2 Allergan Business Overview
11.5.3 Allergan Regenerative Medicine Introduction
11.5.4 Allergan Revenue in Regenerative Medicine Business (2020-2025)
11.5.5 Allergan Recent Development
11.6 MiMedx Group
11.6.1 MiMedx Group Company Details
11.6.2 MiMedx Group Business Overview
11.6.3 MiMedx Group Regenerative Medicine Introduction
11.6.4 MiMedx Group Revenue in Regenerative Medicine Business (2020-2025)
11.6.5 MiMedx Group Recent Development
11.7 Organogenesis
11.7.1 Organogenesis Company Details
11.7.2 Organogenesis Business Overview
11.7.3 Organogenesis Regenerative Medicine Introduction
11.7.4 Organogenesis Revenue in Regenerative Medicine Business (2020-2025)
11.7.5 Organogenesis Recent Development
11.8 Fujifilm Cellular Dynamics
11.8.1 Fujifilm Cellular Dynamics Company Details
11.8.2 Fujifilm Cellular Dynamics Business Overview
11.8.3 Fujifilm Cellular Dynamics Regenerative Medicine Introduction
11.8.4 Fujifilm Cellular Dynamics Revenue in Regenerative Medicine Business (2020-2025)
11.8.5 Fujifilm Cellular Dynamics Recent Development
11.9 Osiris Therapeutics
11.9.1 Osiris Therapeutics Company Details
11.9.2 Osiris Therapeutics Business Overview
11.9.3 Osiris Therapeutics Regenerative Medicine Introduction
11.9.4 Osiris Therapeutics Revenue in Regenerative Medicine Business (2020-2025)
11.9.5 Osiris Therapeutics Recent Development
11.10 Vcanbio
11.10.1 Vcanbio Company Details
11.10.2 Vcanbio Business Overview
11.10.3 Vcanbio Regenerative Medicine Introduction
11.10.4 Vcanbio Revenue in Regenerative Medicine Business (2020-2025)
11.10.5 Vcanbio Recent Development
11.11 CCBC
11.11.1 CCBC Company Details
11.11.2 CCBC Business Overview
11.11.3 CCBC Regenerative Medicine Introduction
11.11.4 CCBC Revenue in Regenerative Medicine Business (2020-2025)
11.11.5 CCBC Recent Development
11.12 Cytori
11.12.1 Cytori Company Details
11.12.2 Cytori Business Overview
11.12.3 Cytori Regenerative Medicine Introduction
11.12.4 Cytori Revenue in Regenerative Medicine Business (2020-2025)
11.12.5 Cytori Recent Development
11.13 Celgene
11.13.1 Celgene Company Details
11.13.2 Celgene Business Overview
11.13.3 Celgene Regenerative Medicine Introduction
11.13.4 Celgene Revenue in Regenerative Medicine Business (2020-2025)
11.13.5 Celgene Recent Development
11.14 Vericel Corporation
11.14.1 Vericel Corporation Company Details
11.14.2 Vericel Corporation Business Overview
11.14.3 Vericel Corporation Regenerative Medicine Introduction
11.14.4 Vericel Corporation Revenue in Regenerative Medicine Business (2020-2025)
11.14.5 Vericel Corporation Recent Development
11.15 Guanhao Biotech
11.15.1 Guanhao Biotech Company Details
11.15.2 Guanhao Biotech Business Overview
11.15.3 Guanhao Biotech Regenerative Medicine Introduction
11.15.4 Guanhao Biotech Revenue in Regenerative Medicine Business (2020-2025)
11.15.5 Guanhao Biotech Recent Development
11.16 Mesoblast
11.16.1 Mesoblast Company Details
11.16.2 Mesoblast Business Overview
11.16.3 Mesoblast Regenerative Medicine Introduction
11.16.4 Mesoblast Revenue in Regenerative Medicine Business (2020-2025)
11.16.5 Mesoblast Recent Development
11.17 AMAG Pharmaceuticals (CBR)
11.17.1 AMAG Pharmaceuticals (CBR) Company Details
11.17.2 AMAG Pharmaceuticals (CBR) Business Overview
11.17.3 AMAG Pharmaceuticals (CBR) Regenerative Medicine Introduction
11.17.4 AMAG Pharmaceuticals (CBR) Revenue in Regenerative Medicine Business (2020-2025)
11.17.5 AMAG Pharmaceuticals (CBR) Recent Development
11.18 ViaCord
11.18.1 ViaCord Company Details
11.18.2 ViaCord Business Overview
11.18.3 ViaCord Regenerative Medicine Introduction
11.18.4 ViaCord Revenue in Regenerative Medicine Business (2020-2025)
11.18.5 ViaCord Recent Development
11.19 CordLife
11.19.1 CordLife Company Details
11.19.2 CordLife Business Overview
11.19.3 CordLife Regenerative Medicine Introduction
11.19.4 CordLife Revenue in Regenerative Medicine Business (2020-2025)
11.19.5 CordLife Recent Development
11.20 Integra LifeSciences
11.20.1 Integra LifeSciences Company Details
11.20.2 Integra LifeSciences Business Overview
11.20.3 Integra LifeSciences Regenerative Medicine Introduction
11.20.4 Integra LifeSciences Revenue in Regenerative Medicine Business (2020-2025)
11.20.5 Integra LifeSciences Recent Development
11.21 Nuvasive
11.21.1 Nuvasive Company Details
11.21.2 Nuvasive Business Overview
11.21.3 Nuvasive Regenerative Medicine Introduction
11.21.4 Nuvasive Revenue in Regenerative Medicine Business (2020-2025)
11.21.5 Nuvasive Recent Development
11.22 Evergen
11.22.1 Evergen Company Details
11.22.2 Evergen Business Overview
11.22.3 Evergen Regenerative Medicine Introduction
11.22.4 Evergen Revenue in Regenerative Medicine Business (2020-2025)
11.22.5 Evergen Recent Development
11.23 Japan Tissue Engineering
11.23.1 Japan Tissue Engineering Company Details
11.23.2 Japan Tissue Engineering Business Overview
11.23.3 Japan Tissue Engineering Regenerative Medicine Introduction
11.23.4 Japan Tissue Engineering Revenue in Regenerative Medicine Business (2020-2025)
11.23.5 Japan Tissue Engineering Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Regenerative Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Cell Therapy
Table 3. Key Players of Tissue Engineering
Table 4. Key Players of Biomaterial
Table 5. Key Players of Other
Table 6. Global Regenerative Medicine Market Size Growth Rate by Material Sources (US$ Million): 2020 VS 2024 VS 2031
Table 7. Key Players of Autologous
Table 8. Key Players of Allogeneic
Table 9. Key Players of Xenogeneic
Table 10. Key Players of Synthetic
Table 11. Global Regenerative Medicine Market Size Growth Rate by End User (US$ Million): 2020 VS 2024 VS 2031
Table 12. Key Players of Children
Table 13. Key Players of Young Adults
Table 14. Key Players of Elderly
Table 15. Global Regenerative Medicine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 16. Global Regenerative Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Regenerative Medicine Market Size by Region (2020-2025) & (US$ Million)
Table 18. Global Regenerative Medicine Market Share by Region (2020-2025)
Table 19. Global Regenerative Medicine Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 20. Global Regenerative Medicine Market Share by Region (2026-2031)
Table 21. Regenerative Medicine Market Trends
Table 22. Regenerative Medicine Market Drivers
Table 23. Regenerative Medicine Market Challenges
Table 24. Regenerative Medicine Market Restraints
Table 25. Global Regenerative Medicine Revenue by Players (2020-2025) & (US$ Million)
Table 26. Global Regenerative Medicine Market Share by Players (2020-2025)
Table 27. Global Top Regenerative Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regenerative Medicine as of 2024)
Table 28. Ranking of Global Top Regenerative Medicine Companies by Revenue (US$ Million) in 2024
Table 29. Global 5 Largest Players Market Share by Regenerative Medicine Revenue (CR5 and HHI) & (2020-2025)
Table 30. Global Key Players of Regenerative Medicine, Headquarters and Area Served
Table 31. Global Key Players of Regenerative Medicine, Product and Application
Table 32. Global Key Players of Regenerative Medicine, Date of Enter into This Industry
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Regenerative Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 35. Global Regenerative Medicine Revenue Market Share by Type (2020-2025)
Table 36. Global Regenerative Medicine Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 37. Global Regenerative Medicine Revenue Market Share by Type (2026-2031)
Table 38. Global Regenerative Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 39. Global Regenerative Medicine Revenue Market Share by Application (2020-2025)
Table 40. Global Regenerative Medicine Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 41. Global Regenerative Medicine Revenue Market Share by Application (2026-2031)
Table 42. North America Regenerative Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. North America Regenerative Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 44. North America Regenerative Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 45. Europe Regenerative Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Europe Regenerative Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 47. Europe Regenerative Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 48. Asia-Pacific Regenerative Medicine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 49. Asia-Pacific Regenerative Medicine Market Size by Region (2020-2025) & (US$ Million)
Table 50. Asia-Pacific Regenerative Medicine Market Size by Region (2026-2031) & (US$ Million)
Table 51. Latin America Regenerative Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 52. Latin America Regenerative Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 53. Latin America Regenerative Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 54. Middle East & Africa Regenerative Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 55. Middle East & Africa Regenerative Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 56. Middle East & Africa Regenerative Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 57. J & J (DePuy Synthes) Company Details
Table 58. J & J (DePuy Synthes) Business Overview
Table 59. J & J (DePuy Synthes) Regenerative Medicine Product
Table 60. J & J (DePuy Synthes) Revenue in Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 61. J & J (DePuy Synthes) Recent Development
Table 62. Medtronic Company Details
Table 63. Medtronic Business Overview
Table 64. Medtronic Regenerative Medicine Product
Table 65. Medtronic Revenue in Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 66. Medtronic Recent Development
Table 67. Zimmer Biomet Company Details
Table 68. Zimmer Biomet Business Overview
Table 69. Zimmer Biomet Regenerative Medicine Product
Table 70. Zimmer Biomet Revenue in Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 71. Zimmer Biomet Recent Development
Table 72. Stryker Company Details
Table 73. Stryker Business Overview
Table 74. Stryker Regenerative Medicine Product
Table 75. Stryker Revenue in Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 76. Stryker Recent Development
Table 77. Allergan Company Details
Table 78. Allergan Business Overview
Table 79. Allergan Regenerative Medicine Product
Table 80. Allergan Revenue in Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 81. Allergan Recent Development
Table 82. MiMedx Group Company Details
Table 83. MiMedx Group Business Overview
Table 84. MiMedx Group Regenerative Medicine Product
Table 85. MiMedx Group Revenue in Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 86. MiMedx Group Recent Development
Table 87. Organogenesis Company Details
Table 88. Organogenesis Business Overview
Table 89. Organogenesis Regenerative Medicine Product
Table 90. Organogenesis Revenue in Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 91. Organogenesis Recent Development
Table 92. Fujifilm Cellular Dynamics Company Details
Table 93. Fujifilm Cellular Dynamics Business Overview
Table 94. Fujifilm Cellular Dynamics Regenerative Medicine Product
Table 95. Fujifilm Cellular Dynamics Revenue in Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 96. Fujifilm Cellular Dynamics Recent Development
Table 97. Osiris Therapeutics Company Details
Table 98. Osiris Therapeutics Business Overview
Table 99. Osiris Therapeutics Regenerative Medicine Product
Table 100. Osiris Therapeutics Revenue in Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 101. Osiris Therapeutics Recent Development
Table 102. Vcanbio Company Details
Table 103. Vcanbio Business Overview
Table 104. Vcanbio Regenerative Medicine Product
Table 105. Vcanbio Revenue in Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 106. Vcanbio Recent Development
Table 107. CCBC Company Details
Table 108. CCBC Business Overview
Table 109. CCBC Regenerative Medicine Product
Table 110. CCBC Revenue in Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 111. CCBC Recent Development
Table 112. Cytori Company Details
Table 113. Cytori Business Overview
Table 114. Cytori Regenerative Medicine Product
Table 115. Cytori Revenue in Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 116. Cytori Recent Development
Table 117. Celgene Company Details
Table 118. Celgene Business Overview
Table 119. Celgene Regenerative Medicine Product
Table 120. Celgene Revenue in Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 121. Celgene Recent Development
Table 122. Vericel Corporation Company Details
Table 123. Vericel Corporation Business Overview
Table 124. Vericel Corporation Regenerative Medicine Product
Table 125. Vericel Corporation Revenue in Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 126. Vericel Corporation Recent Development
Table 127. Guanhao Biotech Company Details
Table 128. Guanhao Biotech Business Overview
Table 129. Guanhao Biotech Regenerative Medicine Product
Table 130. Guanhao Biotech Revenue in Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 131. Guanhao Biotech Recent Development
Table 132. Mesoblast Company Details
Table 133. Mesoblast Business Overview
Table 134. Mesoblast Regenerative Medicine Product
Table 135. Mesoblast Revenue in Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 136. Mesoblast Recent Development
Table 137. AMAG Pharmaceuticals (CBR) Company Details
Table 138. AMAG Pharmaceuticals (CBR) Business Overview
Table 139. AMAG Pharmaceuticals (CBR) Regenerative Medicine Product
Table 140. AMAG Pharmaceuticals (CBR) Revenue in Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 141. AMAG Pharmaceuticals (CBR) Recent Development
Table 142. ViaCord Company Details
Table 143. ViaCord Business Overview
Table 144. ViaCord Regenerative Medicine Product
Table 145. ViaCord Revenue in Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 146. ViaCord Recent Development
Table 147. CordLife Company Details
Table 148. CordLife Business Overview
Table 149. CordLife Regenerative Medicine Product
Table 150. CordLife Revenue in Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 151. CordLife Recent Development
Table 152. Integra LifeSciences Company Details
Table 153. Integra LifeSciences Business Overview
Table 154. Integra LifeSciences Regenerative Medicine Product
Table 155. Integra LifeSciences Revenue in Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 156. Integra LifeSciences Recent Development
Table 157. Nuvasive Company Details
Table 158. Nuvasive Business Overview
Table 159. Nuvasive Regenerative Medicine Product
Table 160. Nuvasive Revenue in Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 161. Nuvasive Recent Development
Table 162. Evergen Company Details
Table 163. Evergen Business Overview
Table 164. Evergen Regenerative Medicine Product
Table 165. Evergen Revenue in Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 166. Evergen Recent Development
Table 167. Japan Tissue Engineering Company Details
Table 168. Japan Tissue Engineering Business Overview
Table 169. Japan Tissue Engineering Regenerative Medicine Product
Table 170. Japan Tissue Engineering Revenue in Regenerative Medicine Business (2020-2025) & (US$ Million)
Table 171. Japan Tissue Engineering Recent Development
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
Table 175. Authors List of This Report


List of Figures
Figure 1. Regenerative Medicine Picture
Figure 2. Global Regenerative Medicine Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Regenerative Medicine Market Share by Type: 2024 VS 2031
Figure 4. Cell Therapy Features
Figure 5. Tissue Engineering Features
Figure 6. Biomaterial Features
Figure 7. Other Features
Figure 8. Global Regenerative Medicine Market Size Comparison by Material Sources (2020-2031) & (US$ Million)
Figure 9. Autologous Features
Figure 10. Allogeneic Features
Figure 11. Xenogeneic Features
Figure 12. Synthetic Features
Figure 13. Global Regenerative Medicine Market Size Comparison by End User (2020-2031) & (US$ Million)
Figure 14. Children Features
Figure 15. Young Adults Features
Figure 16. Elderly Features
Figure 17. Global Regenerative Medicine Market Size by Application (2020-2031) & (US$ Million)
Figure 18. Global Regenerative Medicine Market Share by Application: 2024 VS 2031
Figure 19. Dermatology Case Studies
Figure 20. Cardiovascular Case Studies
Figure 21. CNS Case Studies
Figure 22. Orthopedic Case Studies
Figure 23. Others Case Studies
Figure 24. Regenerative Medicine Report Years Considered
Figure 25. Global Regenerative Medicine Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 26. Global Regenerative Medicine Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 27. Global Regenerative Medicine Market Share by Region: 2024 VS 2031
Figure 28. Global Regenerative Medicine Market Share by Players in 2024
Figure 29. Global Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 30. The Top 10 and 5 Players Market Share by Regenerative Medicine Revenue in 2024
Figure 31. North America Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. North America Regenerative Medicine Market Share by Country (2020-2031)
Figure 33. United States Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Canada Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Europe Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Europe Regenerative Medicine Market Share by Country (2020-2031)
Figure 37. Germany Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. France Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. U.K. Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Italy Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Russia Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Ireland Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Asia-Pacific Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Asia-Pacific Regenerative Medicine Market Share by Region (2020-2031)
Figure 45. China Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Japan Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. South Korea Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Southeast Asia Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. India Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Australia & New Zealand Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Latin America Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Latin America Regenerative Medicine Market Share by Country (2020-2031)
Figure 53. Mexico Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Brazil Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55. Middle East & Africa Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. Middle East & Africa Regenerative Medicine Market Share by Country (2020-2031)
Figure 57. Israel Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 58. Saudi Arabia Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 59. UAE Regenerative Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 60. J & J (DePuy Synthes) Revenue Growth Rate in Regenerative Medicine Business (2020-2025)
Figure 61. Medtronic Revenue Growth Rate in Regenerative Medicine Business (2020-2025)
Figure 62. Zimmer Biomet Revenue Growth Rate in Regenerative Medicine Business (2020-2025)
Figure 63. Stryker Revenue Growth Rate in Regenerative Medicine Business (2020-2025)
Figure 64. Allergan Revenue Growth Rate in Regenerative Medicine Business (2020-2025)
Figure 65. MiMedx Group Revenue Growth Rate in Regenerative Medicine Business (2020-2025)
Figure 66. Organogenesis Revenue Growth Rate in Regenerative Medicine Business (2020-2025)
Figure 67. Fujifilm Cellular Dynamics Revenue Growth Rate in Regenerative Medicine Business (2020-2025)
Figure 68. Osiris Therapeutics Revenue Growth Rate in Regenerative Medicine Business (2020-2025)
Figure 69. Vcanbio Revenue Growth Rate in Regenerative Medicine Business (2020-2025)
Figure 70. CCBC Revenue Growth Rate in Regenerative Medicine Business (2020-2025)
Figure 71. Cytori Revenue Growth Rate in Regenerative Medicine Business (2020-2025)
Figure 72. Celgene Revenue Growth Rate in Regenerative Medicine Business (2020-2025)
Figure 73. Vericel Corporation Revenue Growth Rate in Regenerative Medicine Business (2020-2025)
Figure 74. Guanhao Biotech Revenue Growth Rate in Regenerative Medicine Business (2020-2025)
Figure 75. Mesoblast Revenue Growth Rate in Regenerative Medicine Business (2020-2025)
Figure 76. AMAG Pharmaceuticals (CBR) Revenue Growth Rate in Regenerative Medicine Business (2020-2025)
Figure 77. ViaCord Revenue Growth Rate in Regenerative Medicine Business (2020-2025)
Figure 78. CordLife Revenue Growth Rate in Regenerative Medicine Business (2020-2025)
Figure 79. Integra LifeSciences Revenue Growth Rate in Regenerative Medicine Business (2020-2025)
Figure 80. Nuvasive Revenue Growth Rate in Regenerative Medicine Business (2020-2025)
Figure 81. Evergen Revenue Growth Rate in Regenerative Medicine Business (2020-2025)
Figure 82. Japan Tissue Engineering Revenue Growth Rate in Regenerative Medicine Business (2020-2025)
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies